Potent inhibitors of tRNA-guanine transglycosylase, an enzyme linked to the pathogenicity of the Shigella bacterium: charge-assisted hydrogen bonding.
暂无分享,去创建一个
G. Klebe | F. Diederich | M. Kansy | W. Schweizer | Björn Wagner | T. Ritschel | B. Stengl | Simone R. Hörtner | C. Kramer
[1] Manfred Kansy,et al. Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities , 2007, ChemMedChem.
[2] G. Klebe,et al. Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding. , 2007, Journal of molecular biology.
[3] Gerhard Klebe,et al. Atypical Protonation States in the Active Site of HIV-1 Protease: A Computational Study , 2007, J. Chem. Inf. Model..
[4] Gerhard Klebe,et al. Protonation changes upon ligand binding to trypsin and thrombin: structural interpretation based on pK(a) calculations and ITC experiments. , 2007, Journal of molecular biology.
[5] Gerhard Klebe,et al. Development, validation, and application of adapted PEOE charges to estimate pKa values of functional groups in protein–ligand complexes , 2006, Proteins.
[6] G. Klebe,et al. Synthesis, Biological Evaluation, and Crystallographic Studies of Extended Guanine-Based (lin-Benzoguanine) Inhibitors for tRNA-Guanine Transglycosylase (TGT) , 2006 .
[7] G. Klebe,et al. Mechanism and Substrate Specificity of tRNA–Guanine Transglycosylases (TGTs): tRNA‐Modifying Enzymes from the Three Different Kingdoms of Life Share a Common Catalytic Mechanism , 2005, Chembiochem : a European journal of chemical biology.
[8] F. Diederich,et al. A fluorine scan of the phenylamidinium needle of tricyclic thrombin inhibitors: effects of fluorine substitution on pKa and binding affinity and evidence for intermolecular C-F...CN interactions. , 2004, Organic & biomolecular chemistry.
[9] Gerhard Klebe,et al. Flexible Adaptations in the Structure of the tRNA‐Modifying Enzyme tRNA–Guanine Transglycosylase and Their Implications for Substrate Selectivity, Reaction Mechanism and Structure‐Based Drug Design , 2003, Chembiochem : a European journal of chemical biology.
[10] W. Xie,et al. Chemical trapping and crystal structure of a catalytic tRNA guanine transglycosylase covalent intermediate , 2003, Nature Structural Biology.
[11] D. Iwata‐Reuyl,et al. Biosynthesis of the 7-deazaguanosine hypermodified nucleosides of transfer RNA. , 2003, Bioorganic chemistry.
[12] D. Suck,et al. Slight sequence variations of a common fold explain the substrate specificities of tRNA‐guanine transglycosylases from the three kingdoms , 1997, FEBS letters.
[13] Paul R. Gerber,et al. MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry , 1995, J. Comput. Aided Mol. Des..
[14] S R Jordan,et al. Design and synthesis of novel 6,7-imidazotetrahydroquinoline inhibitors of thymidylate synthase using iterative protein crystal structure analysis. , 1992, Journal of medicinal chemistry.
[15] C. Sasakawa,et al. Virulence‐associated chromosomal loci of Shigella flexneri identified by random Tn5 insertion mutagenesis , 1991, Molecular microbiology.